N-(2-methylpropyl)-3-[(E)-tridec-3-enyl]oxiran-2-amine

C19H37NO — CID 155259031

IUPACN-(2-methylpropyl)-3-[(E)-tridec-3-enyl]oxiran-2-amine
SMILESCCCCCCCCC/C=C/CCC1OC1NCC(C)C
InChIInChI=1S/C19H37NO/c1-4-5-6-7-8-9-10-11-12-13-14-15-18-19(21-18)20-16-17(2)3/h12-13,17-20H,4-11,14-16H2,1-3H3/b13-12+
InChIKeyKAFNJTGMDVDGLL-OUKQBFOZSA-N
MW295.51 g/mol
LogP5.43
Rot. Bonds14

About N-(2-methylpropyl)-3-[(E)-tridec-3-enyl]oxiran-2-amine

N-(2-methylpropyl)-3-[(E)-tridec-3-enyl]oxiran-2-amine (PubChem CID 155259031) has the molecular formula C19H37NO and a molecular weight of 295.51 g/mol. Its IUPAC name is N-(2-methylpropyl)-3-[(E)-tridec-3-enyl]oxiran-2-amine.

Molecular Properties

Compound NameN-(2-methylpropyl)-3-[(E)-tridec-3-enyl]oxiran-2-amine
PubChem CID155259031
Molecular FormulaC19H37NO
Molecular Weight295.51 g/mol
Exact Mass295.29
IUPAC NameN-(2-methylpropyl)-3-[(E)-tridec-3-enyl]oxiran-2-amine
SMILESCCCCCCCCC/C=C/CCC1OC1NCC(C)C
InChIInChI=1S/C19H37NO/c1-4-5-6-7-8-9-10-11-12-13-14-15-18-19(21-18)20-16-17(2)3/h12-13,17-20H,4-11,14-16H2,1-3H3/b13-12+
InChIKeyKAFNJTGMDVDGLL-OUKQBFOZSA-N
XLogP5.43
TPSA24.56 Ų
H-Bond Donors1
H-Bond Acceptors2
Rotatable Bonds14
Heavy Atoms21
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500295.51
LogP ≤ 55.43
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 102

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'Three-membered_heterocycle', 'substructure': 'N/A'}

Analyze N-(2-methylpropyl)-3-[(E)-tridec-3-enyl]oxiran-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[(Z)-octadec-9-enyl]oxiran-2-amine
CID 87359514
N-octadec-9-enyloxiran-2-amine
CID 123463776
N'-(3-nonadeca-4,7,10,13,16-pentaenyloxiran-2-yl)ethane-1,2-diamine
CID 123621725
3-[2-(dimethylamino)ethyl]-N-[(11Z,14Z)-2-[(9Z,12Z)-octadeca-9,12-dienyl]icosa-11,14-dienyl]oxiran-2-amine
CID 130459048
[(Z)-18-methylnonadec-9-enyl]-(oxiran-2-ylmethyl)azanium chloride
CID 140355517
2-[(4Z,7Z,10Z,13Z,16Z)-nonadeca-4,7,10,13,16-pentaenyl]-N-propan-2-yloxiran-2-amine
CID 145665633
3-[(8Z,11Z)-heptadeca-8,11-dienyl]-N-methyloxiran-2-amine
CID 155139215
3-methyl-N-[9-(2-methylcycloprop-2-en-1-yl)nonyl]oxiran-2-amine
CID 164153446
3-[2-(dimethylamino)ethyl]-N-[(6Z,9Z,28Z,31Z)-heptatriaconta-6,9,28,31-tetraen-19-yl]oxiran-2-amine
CID 166762817
3-[3-(dimethylamino)propyl]-N-[(6Z,9Z,28Z,31Z)-heptatriaconta-6,9,28,31-tetraen-19-yl]oxiran-2-amine
CID 166762829
N-(3-aminopropyl)-N'-[3-[[3-[(5Z,8Z,11Z)-heptadeca-5,8,11-trienyl]oxiran-2-yl]amino]propyl]butane-1,4-diamine
CID 172354744
18-methyl-N-(oxiran-2-ylmethyl)nonadec-9-en-1-amine;hydrochloride
CID 173359513

Frequently Asked Questions

What is the IUPAC name of N-(2-methylpropyl)-3-[(E)-tridec-3-enyl]oxiran-2-amine?
The IUPAC name of N-(2-methylpropyl)-3-[(E)-tridec-3-enyl]oxiran-2-amine (CID 155259031) is N-(2-methylpropyl)-3-[(E)-tridec-3-enyl]oxiran-2-amine.
What is the SMILES notation for N-(2-methylpropyl)-3-[(E)-tridec-3-enyl]oxiran-2-amine?
The canonical SMILES for N-(2-methylpropyl)-3-[(E)-tridec-3-enyl]oxiran-2-amine is CCCCCCCCC/C=C/CCC1OC1NCC(C)C.
What is the InChIKey of N-(2-methylpropyl)-3-[(E)-tridec-3-enyl]oxiran-2-amine?
The InChIKey is KAFNJTGMDVDGLL-OUKQBFOZSA-N. The full InChI is InChI=1S/C19H37NO/c1-4-5-6-7-8-9-10-11-12-13-14-15-18-19(21-18)20-16-17(2)3/h12-13,17-20H,4-11,14-16H2,1-3H3/b13-12+.
What are the key properties of N-(2-methylpropyl)-3-[(E)-tridec-3-enyl]oxiran-2-amine?
N-(2-methylpropyl)-3-[(E)-tridec-3-enyl]oxiran-2-amine has a molecular weight of 295.51 g/mol, XLogP of 5.43, 14 rotatable bonds, 1 hydrogen bond donors, and 2 hydrogen bond acceptors.
Where does this data come from?
All data for N-(2-methylpropyl)-3-[(E)-tridec-3-enyl]oxiran-2-amine is sourced from PubChem (CID 155259031), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).